Loading...
Shandong Weigao Group Medical Polymer Company Limited
1066.HK•HKSE
Healthcare
Medical - Instruments & Supplies
HK$6.06
HK$-0.11(-1.78%)
Shandong Weigao Group Medical Polymer Company Limited (1066.HK) Financial Performance & Statements
Review Shandong Weigao Group Medical Polymer Company Limited’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
-1.08%
↓ 1.08%
Operating Income Growth
9.44%
↑ 9.44%
Net Income Growth
3.24%
↑ 3.24%
Operating Cash Flow Growth
-0.31%
↓ 0.31%
Operating Margin
17.37%
↑ 17.37%
Gross Margin
49.94%
↑ 49.94%
Net Profit Margin
15.79%
↑ 15.79%
ROE
8.83%
↑ 8.83%
ROIC
7.92%
↑ 7.92%
Shandong Weigao Group Medical Polymer Company Limited (1066.HK) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Shandong Weigao Group Medical Polymer Company Limited stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $3.23B | $3.23B | $3.32B | $3.32B |
| Cost of Revenue | $1.65B | $1.65B | $1.63B | $1.63B |
| Gross Profit | $1.58B | $1.58B | $1.69B | $1.69B |
| Gross Profit Ratio | $0.49 | $0.49 | $0.51 | $0.51 |
| R&D Expenses | $161.81M | $161.81M | $150.81M | $150.81M |
| SG&A Expenses | $912.89M | $912.89M | $905.91M | $905.91M |
| Operating Expenses | $1.07B | $1.07B | $1.06B | $1.06B |
| Total Costs & Expenses | $2.72B | $2.72B | $2.69B | $2.69B |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $217.35M | $217.41M | $217.41M | $217.41M |
| EBITDA | $722.26M | $722.32M | $848.92M | $848.92M |
| EBITDA Ratio | $0.22 | $0.22 | $0.26 | $0.26 |
| Operating Income | $504.91M | $504.91M | $631.51M | $631.51M |
| Operating Income Ratio | $0.16 | $0.16 | $0.19 | $0.19 |
| Other Income/Expenses (Net) | $88.77M | $88.77M | $51.68M | $51.68M |
| Income Before Tax | $593.68M | $593.68M | $683.19M | $683.19M |
| Income Before Tax Ratio | $0.18 | $0.18 | $0.21 | $0.21 |
| Income Tax Expense | $89.11M | $89.11M | $106.40M | $106.40M |
| Net Income | $479.56M | $479.56M | $553.77M | $553.77M |
| Net Income Ratio | $0.15 | $0.15 | $0.17 | $0.17 |
| EPS | $0.10 | $0.10 | $0.12 | $0.12 |
| Diluted EPS | $0.10 | $0.10 | $0.12 | $0.12 |
| Weighted Avg Shares Outstanding | $4.67B | $4.67B | $4.61B | $4.61B |
| Weighted Avg Shares Outstanding (Diluted) | $4.57B | $4.57B | $4.61B | $4.61B |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan